# Nanobiotix S.A.: Form 20-F for the period ended Dec 31, 2021

- Company: [Nanobiotix S.A.](/companies/nbtx.md) (CIK 1760854)
- Form: 20-F
- Filed: 2022-04-08
- Accepted by EDGAR: Apr 8, 2022, 17:06 ET
- Period: 2021-12-31
- Accession: 0001628280-22-008842
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | EUR 2.6m | ifrs-full:Revenue |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −EUR 52.6m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | EUR 5.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −EUR 47.1m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | −EUR 1.35 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | −EUR 1.35 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | −EUR 29.9m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | EUR 228.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2021-12-31 | EUR 83.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2021-12-31 | EUR 93.1m | ifrs-full:CurrentAssets |
| Total assets | at 2021-12-31 | EUR 101.8m | ifrs-full:Assets |
| Current liabilities | at 2021-12-31 | EUR 36.8m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2021-12-31 | EUR 26.8m | ifrs-full:Equity |
| Shares outstanding | at 2021-12-31 | 34,825,872 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm

Filed Apr 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-008842. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.